Skip to content
Screener

Total Equity at other companies

GPA
General Purpose Acquisition Corp.GPAC
-$7.87M+38.7%
Veradermics logo
VeradermicsMANE
$390.64M+744%
BK
BKBK
$44.78B+3.9%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$2.49M-41.5%
Schering-Plough logo
Schering-PloughSGP
$250.11M+463%
Dollar General logo
Dollar GeneralDG
$8.84B+14.8%

Other financials

Income statement

See full
Revenue--100%
Operating income-$55.5M-32.3%
Net income-$52.8M-28.0%
EPS (diluted)-$1.74+94.1%

Balance sheet

See full
Cash & equivalents$82.0M-49.7%
Total debt$24.8M+8,175%
Total assets$483.9M

Cash flow

See full
Operating cash flow-$34.5M-0.7%
CapEx$186.0K+541%
Free cash flow-$34.7M-1.2%

Valuation

See full
Market cap$1B+27.8%
Enterprise value$946.17M
P/S348.8×

Profitability

See full
Operating margin-6,129%
Net margin-5,934%
FCF margin-5,203.9%

Returns & leverage

See full
Return on equity-8,434.8%
Debt / equity0.1×
Current ratio11.4×

Where this comes from

Reported directly by Odyssey Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Odyssey Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335822

FAQ

What is Odyssey Therapeutics's total equity?
Odyssey Therapeutics (ODTX) reported total equity of $421.22M in Q2 2026.
How has Odyssey Therapeutics's total equity changed year-over-year?
Odyssey Therapeutics's total equity increased by 196.5% year-over-year, from -$436.36M to $421.22M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Odyssey Therapeutics's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude